COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice

Esmaeil Mehraeen1, Shahram Oliaei2, SeyedAhmad SeyedAlinaghi3

  • 1Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.

Insights

Children infected with SARS-CoV-2 (the virus that causes COVID-19) often have mild symptoms and can be silent carriers. This systematic review highlights the clinical aspects and public health implications of COVID-19 in pediatric populations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • SARS-CoV-2 causes COVID-19, a global health concern.
  • Children typically present with mild or asymptomatic SARS-CoV-2 infections, posing challenges for diagnosis and disease control.
  • Understanding COVID-19 in children is crucial for public health strategies.

Purpose of the Study:

  • To conduct a comprehensive systematic review of the current knowledge on COVID-19 in children.
  • To reflect on the clinical and paraclinical aspects of SARS-CoV-2 infection in pediatric populations.
  • To inform current practices regarding pediatric COVID-19 management.

Main Methods:

  • Systematic review of literature published up to October 2020.
  • Systematic search of online databases using relevant keywords.
  • Adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist for quality assurance.

Main Results:

  • 23 studies were selected from 1744 initial papers.
  • The majority of publications originated from China, but data from multiple countries were included.
  • Children can experience systemic involvement and various symptoms, though generally less severe than in adults.

Conclusions:

  • COVID-19 in children can manifest with systemic involvement, but prevalence and severity are lower than in adults.
  • Common symptoms include cough and fever; gastrointestinal issues and comorbidities can also occur.
  • Mental health impacts, such as anxiety and depression, are significant in children during the pandemic and require clinical attention.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
46